DUBA antikoerper, AA407879 antikoerper, AI553596 antikoerper, BB114028 antikoerper, DXImx46e antikoerper, Sfc7 antikoerper, otud5 antikoerper, si:bz30i22.1 antikoerper, si:rp71-30i22.1 antikoerper, zgc:154072 antikoerper, wu:fi28a06 antikoerper, zgc:100839 antikoerper, OTU deubiquitinase 5 antikoerper, OTU domain containing 5 antikoerper, OTU deubiquitinase 5a antikoerper, OTU deubiquitinase 5 S homeolog antikoerper, OTU deubiquitinase 5 L homeolog antikoerper, OTU deubiquitinase 5b antikoerper, OTUD5 antikoerper, Otud5 antikoerper, otud5a antikoerper, otud5.S antikoerper, otud5.L antikoerper, otud5b antikoerper
Hintergrund
DUBA belongs to a subfamily of 14 DUBs characterized by an OTU (Ovarian Tumor) domain. This protein suppress the type I interferon-dependent innate immune response by cleaving the polyubiquitin chain from an essential type I interferon adaptor protein. Cleavage results in disassociation of the adaptor protein from a downstream signaling complex and disruption of the type I interferon signaling cascade. DUBA forms a direct complex with p53 and controls level of ubiquitination. The function of DUBA is required to allow the rapid activation of p53-dependent transcription and a p53-dependent apoptosis in response to DNA damage stress.